ArticleACS infectious diseases2026
Aerocavin Is an Antibiotic with Potent and Specific Anti-Neisserial Activity.
Gleb Pishchany, Kyra E Fryling, Vineetha Vasukuttan, Yern-Hyerk Shin, Tatum D Mortimer, Yonatan H Grad, Jon Clardy
Abstract read
In one paragraphArticle in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
7 authors.
Gleb PishchanyCenter for Therapeutics, Toxicology, and Devices, RTI International, Durham, North Carolina 27709, United States.ORCID 0000-0001-9303-010X Kyra E FrylingDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, United States.
Vineetha VasukuttanCenter for Therapeutics, Toxicology, and Devices, RTI International, Durham, North Carolina 27709, United States.
Yern-Hyerk ShinDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United States.ORCID 0000-0003-4645-2128 Tatum D MortimerDepartment of Population Health, University of Georgia, Athens, Georgia 30602, United States.
Yonatan H GradDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, United States.
Jon ClardyDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Blavatnik Institute, Boston, Massachusetts 02115, United States.ORCID 0000-0003-0213-8356 Funding
Genomics approaches to elucidating pathways to antibiotic resistance in Neisseria gonorrhoeaeR01AI132606 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Yonatan H Grad · 2017 to 2026
$3.8MNIAID NIH HHS R01 AI132606
6 · The paper itselfAbstract
Indexed as
Anti-Bacterial AgentsNeisseria gonorrhoeaeDNA-Directed RNA PolymerasesDrug Resistance, BacterialGonorrheaHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsDNA-Directed RNA Polymerasesaerocavingonorrheanarrow-spectrum antibioticsNeisseriaripostatinRNA polymerase
Identifiers
PMID42283450
PMCPMC13326619
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390